title: [Percutaneous aortic valve replacement in high risk patients].
abstract: The degenerative, calcified aortic stenosis is the most common form of adult valvular heart disease. Surgical aortic valve replacement is the method of choice and can be performed at low risk in suitable candidates. However, a fair amount of patients is rejected from surgery due to old age and preexisting comorbidities increasing operative mortality. For this reason frequently operation is not accomplished. Today, with the development of percutaneous aortic valve replacement, the treatment of aortic stenosis has entered a new era providing a new durable treatment option.
authors.affiliation: Abteilung für Kardiologie, Universitätsklinikum Rostock, Rostock.
authors.forename: T
authors.initials: T
authors.lastname: Chatterjee
authors.forename: C A
authors.initials: CA
authors.lastname: Nienaber
authors.forename: H
authors.initials: H
authors.lastname: Schneider
authors.forename: S
authors.initials: S
authors.lastname: Kische
authors.forename: I
authors.initials: I
authors.lastname: Akin
authors.forename: T C
authors.initials: TC
authors.lastname: Rehders
authors.forename: A
authors.initials: A
authors.lastname: Liebold
authors.forename: J
authors.initials: J
authors.lastname: Ortak
authors.forename: H
authors.initials: H
authors.lastname: Ince
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000497:Alloys; D000792:Angiography; D017130:Angioplasty / Q000295:instrumentation*; D001024:Aortic Valve Stenosis / Q000000981:diagnostic imaging / Q000601:surgery*; D001705:Bioprosthesis; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D011474:Prosthesis Design
chemical_list: D000497:Alloys; C013616:nitinol